This site is intended for healthcare professionals only

Sponsor

Bowel Cancer UK

Company profile

Bowel Cancer UK is the UK’s leading bowel cancer charity, determined to save lives and improve the quality of life of everyone affected by bowel cancer. We work with health professionals across the UK to improve the treatment, care and support for people affected by bowel cancer. We provide educational opportunities and health information to support you and your patients.

Resources

Briefing document

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

Best Practice Guide

Symptoms Diary

Company profile

At Macmillan, we give people with cancer everything we’ve got. If you’re diagnosed, your worries are our worries. We will move mountains to help you live life as fully as you can. And we don’t stop there. We’re going all out to find ever better ways to help people with cancer, helping to bring forward the day when everyone gets life-transforming support from day one. We’ll do whatever it takes.

Resources

Cancer Care Review

This resource has been developed, organised and funded by Boehringer Ingelheim. The content has been reviewed and approved by the sponsoring company prior to the symposium. Editorial support for this symposium has been provided by OmniaMed Communications.

Primary Care Network Early Diagnosis Support

Stay up to date with our Primary Care Newsletter

Social Prescribing 10 Top Tips

UKONS and Macmillan Oncology and Haematology Risk Assessment Tool:

Sign up to access eLearning

Sponsor

Prostate Cancer UK

Company profile

Prostate Cancer UK’s top priority is funding research to stop prostate cancer killing men. We’re investing millions to find better treatments and better tests that can spot fast-growing cancers early, and could be used in a screening programme to save thousands of lives.

We were the first national organisation for prostate cancer in the UK. Our aim was to improve the care and welfare of those affected by prostate cancer, increase investment in research, and raise public and political awareness of a long-neglected disease. In the last 20 years, we’ve invested over £37 million into ground breaking research, and continue to provide award-winning support for men.

We have grown in size, strength and influence but our ambition is the same: to put men at the heart of everything we do.

Resources

Prostate Cancer Specialist course

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

Resources for Health Professionals- Risk Campaign

Prostate Cancer Risk Management Programme and Prostate Cancer UK’s Consensus Statements on PSA testing

Chronic prostatitis and chronic pelvic pain syndrome: a consensus guideline

This quick reference guide contains priorities for implementation and a treatment algorithm.

PSA Consensus Statements

Our PSA consensus statements represent the consensus view of hundreds of health professionals, to support primary health care professionals to use the PSA test more effectively for men without symptoms of prostate cancer.

PCRMP & Prostate Cancer UK Consensus statements

Summary leaflet of Public Heath England’s Prostate Cancer Risk Management Programme guidance (2016) and Prostate Cancer UK’s ‘Consensus statements on PSA testing in asymptomatic men in the UK’ (2016) for GPs.

Resources

Male Urology in Primary Care Course

Our Male Urology in Primary Care online learning course provides practical and bitesize modules to support you when treating patients with benign disease and prostate cancer. You can complete the course at your own pace, and it’s a chance to earn CPD.

Treating erectile dysfunction after surgery for pelvic cancers and after radical radiotherapy and androgen deprivation therapy (ADT) for prostate cancer

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. 

PCRMP & Prostate Cancer UK Consensus statements

Summary leaflet of Public Heath England’s Prostate Cancer Risk Management Programme guidance (2016) and Prostate Cancer UK’s ‘Consensus statements on PSA testing in asymptomatic men in the UK’ (2016) for GPs.

Chronic prostatitis and chronic pelvic pain syndrome: a consensus guideline

This quick reference guide contains priorities for implementation and a treatment algorithm.

PSA Consensus Statements

Our PSA consensus statements represent the consensus view of hundreds of health professionals, to support primary health care professionals to use the PSA test more effectively for men without symptoms of prostate cancer.

PCRMP & Prostate Cancer UK Consensus statements

Summary leaflet of Public Heath England’s Prostate Cancer Risk Management Programme guidance (2016) and Prostate Cancer UK’s ‘Consensus statements on PSA testing in asymptomatic men in the UK’ (2016) for GPs.

chronic-conditions-logo-white
© Copyright Omniamed Communications. All Rights Reserved 108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom